PUNE, India, May 11, 2023 /PRNewswire/ -- According to a recent market study published by Growth Market Reports, titled, "Global MRI Contrast Agents Market by Products (Paramagnetic Contrast Agents and Superparamagnetic Contrast Agents), Types (Preclinical and Clinical), Application( Gastrointestinal, Intravenous, Hepatobiliary, Neurological Imaging, and Others), Route of Administration (Intravascular and Oral), End-users (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), Modality (X-ray, CT scan, Ultrasound, and MRI scan), and Regions: Size, Share, Trends, and Opportunity Analysis, 2023-2031", the market was valued at USD 1.65 Bn in 2022 and is expected to reach USD 2.41Bn expanding at a CAGR of 4.30% by the end of 2031. The market growth is attributed to the increasing awareness about early diagnosis of health complications and the rising need for advanced imaging techniques in the healthcare sector.
Key Market Players Profiled in the Report
- Bayer AG
- Bracco Diagnostics
- Guerbet
- Jiangsu Hengrui Pharmaceutical Co. Ltd
- Lantheus Medical Imaging, Inc
- General Electric Company
- LIVEALTH
- Nano Therapeutics Pvt. Ltd
- Spago Nanomedical AB
- Magnus Health
- Trivitron Healthcare
- Beijing BeiLu Pharmaceutical Co., Ltd
- Rege Imaging & Cine Films Private Limited
- Unijules Life Sciences Ltd
- Megapro Biomedical Co. Ltd.
- J B Chemicals and Pharmaceuticals Ltd.
Download PDF Sample here: https://growthmarketreports.com/request-sample/218
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that change the market dynamics of the industry. It provides an in-depth analysis of the market segments, which include products, applications, and competitor analysis.
This report also includes a complete analysis of industry players and covers their latest developments, product portfolio, pricing, mergers, acquisitions, and collaborations. Moreover, it provides crucial strategies that are helping market players to expand their market share.
Highlights on the Segments of the Global MRI Contrast Agents Market
On the basis of product type, the global MRI contrast agents market is divided into paramagnetic contrast agents and superparamagnetic contrast agents. The paramagnetic contrast agents segment is expected to expand at a significant growth rate during the projection period, due to its easy availability and administration techniques. These agents provide good clinical outcomes with enhanced imaging of organs.
Based on type, the global MRI contrast agents market is bifurcated into preclinical and clinical. The clinical segment is expected to register robust growth during the forecast period, due to its use before and during surgeries for enhanced visibility of the organs. MRI contrast agents improve the signal intensity of tissues by reducing the time taken by water protons to level up with the magnetic field created by the imaging machine. This characteristic of the contrast agents helps in improving the clinical outcome by helping surgeons in clear imaging.
In terms of application, the global market is segregated into gastrointestinal, intravenous, hepatobiliary, neurological imaging, and others. The neurological imaging segment is projected to expand at a considerable CAGR during the forecast period, owing to the rising use of MRI contrast agents in studying complex neurological abnormalities with the help of imaging. Contrast agents used in MRI during neurological scanning provide high-precision imaging to help doctors plan a suitable line of treatment for patients.
To Buy the Complete Report: https://growthmarketreports.com/report/mri-contrast-agents-market-global-industry-analysis
On the basis of the route of administration, the global MRI contrast agents market is segmented into intravascular and oral. The intravascular segment is expected to register robust growth during the forecast period, owing to enhanced visibility of body structures such as blood vessels, tracts, and issues. The intravenous type of administration is effective, as it leads to immediate and improved imaging results.
Based on end-user, the global MRI contrast agents market is segmented into hospitals, ambulatory surgical centers, and diagnostic centers. The hospital segment is projected to expand at a considerable CAGR during the forecast period, owing to the substantial rise in the installed base of MRI units in hospitals and the high patient visit rate at these medical institutions. Other factors propelling the hospital segment are the growing rate of chronic diseases such as colon cancer, diabetes, and heart failure.
For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/218
On the basis of modality, the global MRI contrast agents market is segregated into X-ray, CT scan, ultrasound, and MRI scan. The CT scan segment is expected to register a robust growth rate during the forecast period, due to high-resolution 3D images provided by contrast agents. The use of contrast agents for CT scans enhances the visibility of organs, body tissues, and blood vessels by blocking the X-rays and highlighting the tissues in the body.
In terms of region, the global MRI contrast agents market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, owing to growing investments in research activities and the presence of well-established healthcare infrastructure to develop effective MRI contrast agents. Growing incidences of cancer and cardiac disorders and rising advancements in diagnostic imaging technology are expected to fuel the MRI contrast agents market in Europe during the forecast period.
Get Full Access to this Report: https://growthmarketreports.com/checkout/218
Key Takeaways from the Study:
- Increasing demand for accurate imaging in clinical practices for the diagnosis and treatment of diseases and health complications elevates the growth of the MRI contrast agents market.
- Rising prevalence of complex chronic diseases and health complications and the subsequent requirement of high-quality imaging for the purpose of choosing an optimum line of treatment is fueling the market.
- Health concerns associated with the health complications of contrast agents hamper the market growth.
- Improvements in the healthcare infrastructure and technical innovations in the medical equipment to facilitate efficient health services boost the demand for MRI contrast agents.
- Rising awareness about conducting preventive diagnosis for suitable treatment methods and high acceptance of high-quality imaging in the healthcare sector drives the market.
Read 239 Pages Research Report with Detailed TOC on "Global MRI Contrast Agents Market by Product (Paramagnetic Contrast Agents and Superparamagnetic Contrast Agents), Type (Preclinical and Clinical), Application( Gastrointestinal, Intravenous, Hepatobiliary, Neurological Imaging, and Others), Route of Administration (Intravascular and Oral), End-users (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), Modality (X-ray, CT scan, Ultrasound, and MRI scan), and Regions: Size, Share, Trends, and Opportunity Analysis, 2023-2031"
Key Segments Covered
Product
- Paramagnetic Contrast Agents
- Superparamagnetic Contrast Agents
Type
- Preclinical
- Clinical
Application
- Gastrointestinal
- Intravenous
- Hepatobiliary
- Neurological Imaging
- Others
Route of Administration
- Intravascular
- Oral
End-user
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
Modality
- X-ray
- CT scan
- Ultrasound
- MRI scan
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Other Related Reports:
- Open System MRI Market by Resolutions (Low-field Scanner, Mid-field Scanner, and High-field Scanner), Applications (Cardiology, Neurology, Gastroenterology, Oncology, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 - 2028
- Global Medical Imaging Systems Marketby Type (Computed Tomography (CT) Scanners, X-Ray Imaging Systems, Magnetic Resonance Imaging (MRI) Systems, Ultrasound Imaging Systems, Nuclear Imaging Systems, Mammography Systems), By Application (Obstetrics/Gynecology (OB/GYN) Health, Orthopedics and Musculoskeletal, Neuro and Spine, Cardiovascular and Thoracic, General Imaging, Breast Health) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030
- Global MRI Contrast Media Market by Type (Injection Type, Oral Type), By Application (Hospitals, Clinics) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
- Global Contrast Media API Market by Type (Iodine, Gadolinium), By Application (X-ray & CT, MRI, Ultrasound) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030
About Growth Market Reports:
Growth Market Reports provides global enterprises as well as small & medium businesses with unmatched quality of "Market Research Reports" and "Industry Intelligence Solutions". Growth Market Reports has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.
Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, and secondary research & consumer surveys.
Contact:
Alex Mathews
7th Floor, Siddh Icon,
Baner Road, Pune.
Maharashtra - 411045. India.
Phone: +1 909 414 1393
Email: sales@growthmarketreports.com
Web: https://growthmarketreports.com/
Twitter: https://twitter.com/growth_reports
LinkedIn: https://www.linkedin.com/company/growth-market-report/
Logo: https://mma.prnewswire.com/media/1980656/Growth_Market_Reports_Logo1.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-mri-contrast-agents-market-set-to-reach-usd-2-41-bn-by-2031--with-a-sustainable-cagr-of-4-30--growth-market-reports-301822062.html
